Question 1

What is the catalog number for VPS29 Human?

Accepted Answer

The catalog number for VPS29 Human is OM296325.

Question 2

What sizes are available for VPS29 Human?

Accepted Answer

VPS29 Human is available in the following size(s): 1 µg, 5 µg, 50 µg.

Question 3

How many pack sizes does VPS29 Human come in?

Accepted Answer

VPS29 Human is available in 3 different pack sizes.

Question 4

Is VPS29 Human in stock?

Accepted Answer

VPS29 Human is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

VPS29 Human

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

TSC2 (Tuberous Sclerosis Complex 2, Tuberous Sclerosis 2 Protein, FLJ43106, LAM, TSC4, Tuberin) (MaxLight 750)

TSC2 (Tuberous Sclerosis Complex 2, Tuberous Sclerosis 2 Protein, FLJ43106, LAM, TSC4, Tuberin) (MaxLight 750)

Recombinant Moringa oleifera Flocculent-active proteins MO2.1 and MO2.2

Recombinant Moringa oleifera Flocculent-active proteins MO2.1 and MO2.2

Recombinant Moringa oleifera Flocculent-active proteins MO2.1 and MO2.2

Recombinant Moringa oleifera Flocculent-active proteins MO2.1 and MO2.2